18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Recruiting	Not stated	2026-03-31		NCT07077213

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital Medical Center, Cincinnati	229
National Institute of Allergy and Infectious Diseases (NIAID)	402
National Institutes of Health (NIH)	667
SOFIE	5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405